Although the above-described growth and anti-apoptotic effects were not mediated by the products of 12-lipoxygenase, the latter pathway also plays a variety of roles in prostate cancer, including the 12(S)-HETE mediated secretion of MMP9 and VEGF [170,171,172]. This evidence concerns the gene VEGFA and prostate carcinoma.